Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist.
about
Copper chelation represses the vascular response to injuryIL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin BLevel of inflammatory cytokines in rheumatoid arthritis patients: Correlation with 25-hydroxy vitamin D and reactive oxygen species.The role of interleukin-1beta in direct and toll-like receptor 4-mediated neutrophil activation and survival.Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophilsThe role of IL-1β in the bone loss during rheumatic diseases.Deficiency of interleukin-1 receptor antagonist responsive to anakinra.Effect evaluation of interleukin-1 receptor antagonist nanoparticles for mesenchymal stem cell transplantation.Regulation of autoimmune inflammation by pro-inflammatory cytokinesCoronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia.Protective effect of curcumin on experimentally induced arthritic rats: detailed histopathological study of the joints and white blood cell count.Strontium ranelate in fracture healing and joint pain improvement in a rheumatoid arthritis patientThe expanding role of IL-7 and thymic stromal lymphopoietin as therapeutic target for rheumatoid arthritis.Selected cytokine pathways in rheumatoid arthritis.A review on interleukins: The key manipulators in rheumatoid arthritis.Novel drug delivery of dual acting prodrugs of hydroxychloroquine with aryl acetic acid NSAIDs: Design, kinetics and pharmacological study.Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability.The Potential of Circadian Realignment in Rheumatoid Arthritis.Cytokines and cellular interactions in inflammatory synovitis.DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytes.Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis.High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering.Differentially methylated alleles in a distinct region of the human interleukin-1alpha promoter are associated with allele-specific expression of IL-1alpha in CD4+ T cells.Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase.Mesenchymal stem cells ameliorate experimental arthritis via expression of interleukin-1 receptor antagonist.Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.K/B×N serum transfer arthritis is delayed and less severe in leukaemia inhibitory factor (LIF)-deficient mice.
P2860
Q28570754-5ACD7924-3648-4B4B-90D3-7C9565EFD596Q30251741-F7DD247C-8979-4373-9FAA-7E1F76B015C8Q33722067-B36C1CEA-06CF-461A-B3C1-DA809F878EDCQ33778590-BA0B59FA-EF4A-46A3-B1CE-4C5195139F88Q35103433-381CA6A9-A424-4B5F-A478-77326D3E05E3Q35537789-A3906037-246F-4FBC-9170-D1F4AAD7A9ACQ35540844-AE135730-A67D-4AAD-9918-DFB37C7709A3Q36542299-06F9F8AA-F1B0-4A42-A8D0-EC0653134B78Q36731213-462E0E25-FE73-4F11-9545-27B9B36B0CE0Q36958814-18785F97-20C7-4E7B-9823-07ABF65FBEC0Q37009878-8DAF99FB-FC3C-4150-B292-FFB0E35E2CC7Q37054188-8E3B7587-BE1A-4957-B150-8399C869FADBQ37567222-A3E75913-AAED-417E-AA74-0CA11D2347DAQ38196882-4589E244-9F53-4434-8641-23AEE3F13255Q38755912-0936AA4B-9C9F-4483-90EE-865FEA3534D1Q39029629-38B9B311-CC5E-4971-BA60-FF51BEC32F88Q39151076-921599B3-5485-4DA2-BB31-061F9654280FQ39246542-B1FC9DEC-FFD3-4EDF-ADCD-D9233EF5E4E8Q39366944-AE686F7E-4131-41BA-A705-6FCF805466CDQ39946607-4FFF6908-4AB8-4068-BFC4-2844EAB8F1D0Q40715481-1F9B0B52-B01A-44AC-9C4F-92AD08E11593Q41809691-30FC7797-0B9E-428E-8D69-2DC27945BA60Q41987472-56DD88E3-B68C-49AD-9A42-81607711F131Q42742059-85E1D4D6-BCC4-49F6-B3B6-0FD071668633Q47322523-B8651790-0497-4FC3-B9E1-0BC060A49D2DQ52730350-9646C9F1-52A3-46AA-9A33-D09932787D97Q52842630-0A150551-D440-479C-86FA-31C01866C0A8Q54301830-E0196EE5-E517-430A-A92C-DB88AC56AB6E
P2860
Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@ast
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@en
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@nl
type
label
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@ast
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@en
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@nl
prefLabel
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@ast
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@en
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@nl
P356
P1476
Cytokine imbalance in the path ...... rleukin-1 receptor antagonist.
@en
P2093
P356
10.1053/SARH.2001.23693
P433
P577
2001-04-01T00:00:00Z